Ceftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem for Participants With Complicated Intra-abdominal Infection (MK-7625A-015) — 7625ACNPhase3

Complicated Intra-abdominal Infections Clinical Trial

Official title:
A Phase 3, Multicenter, Double-blind, Randomized, Active-controlled Clinical Study to Evaluate the Efficacy and Safety of Ceftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem in Chinese Participants With Complicated Intra-abdominal Infection

Status Completed

Clinical Trial Summary

This study aims to evaluate the efficacy of ceftolozane/tazobactam (MK-7625A) plus metronidazole versus meropenem in adults diagnosed with complicated intra-abdominal infection (cIAI). The primary hypothesis is ceftolozane/tazobactam plus metronidazole is non-inferior to meropenem, as measured by the clinical response rate at the Test-of Cure (TOC) visit in the Clinically Evaluable (CE) population.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Communicable Diseases
Complicated Intra-abdominal Infections
Infections
Intraabdominal Infections

Clinical Trial Details

NCT number	NCT03830333
Study type	Interventional
Source	Merck Sharp & Dohme LLC
Contact
Status	Completed
Phase	Phase 3
Start date	March 20, 2019
Completion date	October 14, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00389987` - Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-037)	Phase 3
Completed	`NCT02784704` - Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections	Phase 3
Completed	`NCT01072539` - Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline Treatment
Completed	`NCT00752219` - Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections	Phase 2
Not yet recruiting	`NCT03678298` - Italian Register for the Study of Complicated Intra-Abdominal Infections
Active, not recruiting	`NCT00860587` - Antibiotic Resistant Bacteria Among Patients With Severe Intraabdominal Infections	N/A
Completed	`NCT01844856` - Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections	Phase 3
Completed	`NCT02475733` - Evaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Children Aged 3 Months to 18 Years Old With Complicated Intra-abdominal Infections (cIAIs).	Phase 2
Completed	`NCT00683332` - Post-Marketing Study Of The Safety Of Tygacil (Tigecycline)	N/A